On Market View Minutes, Michelle Martin discusses Pfizer's 3.5 billion USD in revenue from the first quarter of the year, Moderna's share price and what a vaccine patent could mean for these companies. 

<p>On Market View Minutes, Michelle Martin discusses Pfizer's 3.5 billion USD in revenue from the first quarter of the year,&nbsp;Moderna's share price and what a vaccine patent could mean for these companies.&nbsp;</p>